Liu S, Li X, Yang J, Zhu R, Fan Z, Xu X, et al. Misfolded proinsulin impairs processing of precursor of insulin receptor and insulin signaling in β cells. FASEB J. 2019;33:11338-11348 pubmed publisher

Wu D, Lv D, Zhang T, Guo L, Ma F, Zhang C, et al. Antitumor effects of β-elemene via targeting the phosphorylation of insulin receptor. Endocr Relat Cancer. 2018;: pubmed publisher

Chen L, Chai K. Proteolytic cleavages in the extracellular domain of receptor tyrosine kinases by membrane-associated serine proteases. Oncotarget. 2017;8:56490-56505 pubmed publisher

Swaminathan S, Ahlschwede K, Sarma V, Curran G, Omtri R, Decklever T, et al. Insulin differentially affects the distribution kinetics of amyloid beta 40 and 42 in plasma and brain. J Cereb Blood Flow Metab. 2018;38:904-918 pubmed publisher

Lv D, Liu J, Guo L, Wu D, Matsumoto K, Huang L. PRAS40 deregulates apoptosis in Ewing sarcoma family tumors by enhancing the insulin receptor/Akt and mTOR signaling pathways. Am J Cancer Res. 2016;6:486-97 pubmed

Qian X, Kraft J, Ni Y, Zhao F. Production of recombinant human proinsulin in the milk of transgenic mice. Sci Rep. 2014;4:6465 pubmed publisher

Jacob K, Whittaker J, Stanley F. Insulin receptor tyrosine kinase activity and phosphorylation of tyrosines 1162 and 1163 are required for insulin-increased prolactin gene expression. Mol Cell Endocrinol. 2002;186:7-16 pubmed